申请人:ABBVIE INC
公开号:WO2016200851A1
公开(公告)日:2016-12-15
The invention provides compounds of Formula (I), pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.